证券之星消息，中国石化发布业绩预告，预计2025年1-6月归属净利润盈利201亿元至216亿元。 公告中解释本次业绩变动的原因为： 2025年上半年,面对严峻复杂的经营形势,公司加大生产经营优化力度,从严从紧控制成本费用。但受国际 原油价格大幅下跌、石油石化市场竞争激烈、化工市场毛利低迷等因素影响,上半年归属于母公司股东 的净利润同比下降。 中国石化2025年一季报显示，公司主营收入7353.56亿元，同比下降6.91%；归母净利润132.64亿元，同 比下降27.58%；扣非净利润132.23亿元，同比下降27.29%；负债率53.35%，投资收益16.47亿元，财务 费用45.79亿元，毛利率15.66%。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 ...

证券之星消息，中国石化发布业绩预告，预计2025年1-6月扣非后净利润盈利200亿元至215亿元。 中国石化2025年一季报显示，公司主营收入7353.56亿元，同比下降6.91%；归母净利润132.64亿元，同 比下降27.58%；扣非净利润132.23亿元，同比下降27.29%；负债率53.35%，投资收益16.47亿元，财务 费用45.79亿元，毛利率15.66%。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 公告中解释本次业绩变动的原因为： 2025年上半年,面对严峻复杂的经营形势,公司加大生产经营优化力度,从严从紧控制成本费用。但受国际 原油价格大幅下跌、石油石化市场竞争激烈、化工市场毛利低迷等因素影响,上半年归属于母公司股东 的净利润同比下降。 ...

每经记者｜陈晴 每经编辑｜魏官红 并购重组 达瑞电子：拟以增资及股权收购方式取得维斯德80%股权 中国石化公告，按中国企业会计准则，预计公司2025年上半年实现归属于母公司股东的净利润为201亿 元至216亿元，与上年同期相比，将下降39.5%至43.7%。 青岛银行：2025年上半年归母净利润30.65亿元，同比增长16.05% 青岛银行公告，2025年上半年营业收入76.62亿元，同比增长7.50%；归母净利润30.65亿元，同比增长 16.05%。 增减持 达瑞电子7月31日晚间公告，公司拟以3000万元认购东莞市维斯德新材料技术有限公司新增注册资本 171.43万元，并以1.34亿元受让麦德坤、饶熙怡本次交易前持有的维斯德76.57%股权。本次交易完成 后，公司将持有维斯德80%股权。 济川药业：曹飞完成要约收购交割，直接及间接控制公司56.07%股份 济川药业7月31日公告称，曹飞要约收购公司股份已完成交割。交割完成后，曹飞直接及间接控制公司 股份合计5.17亿股，占公司总股本的56.07%。曹飞及其一致行动人曹龙祥共同控制公司5.64亿股股份， 占公司总股本的61.15%。 业绩披露 捷佳伟创：上 ...

【中国石化：预计上半年净利润为人民币201亿元—216亿元 将持续加大生产经营优化力度】中国石化 披露2025年半年度业绩预告，受国际原油价格大幅下跌、石油石化市场竞争激烈、化工市场毛利低迷等 因素影响，公司业绩表现同比下降，预计2025年上半年实现归母净利润为人民币201亿元—216亿元。中 国石化表示：公司将持续加大生产经营优化力度，推动产业转型升级、科技创新和产业创新深度融合， 不断提升核心竞争力，实现高质量发展。(智通财经） ...

Performance Updates - 开拓药业-B (09939.HK) has completed patient enrollment for the Phase III clinical trial of KX-826 solution for androgenetic alopecia in adult males in China [2] - 李氏大药厂 (00950.HK) has received approval from the National Medical Products Administration for Socazolimab to be used in combination with chemotherapy for first-line treatment of extensive-stage small cell lung cancer in mainland China [2] - 恒瑞医药 (01276.HK) has received approval for clinical trials of SHR-8068 injection, Adebali monoclonal antibody injection, and Bevacizumab injection [2] - 恒瑞医药 (01276.HK) has also received approval to conduct clinical trials for HRS-5041, intended for prostate cancer treatment [2] - 深圳高速公路股份 (00548.HK) reported toll revenue of 106 million yuan for the outer ring project in June [2] - 大成生化科技 (00809.HK) has signed an EPC contract with Northeast Electric and Liaoning Electric for boiler renovation projects, with a maximum cost of 129.1 million yuan [2] - 小黄鸭德盈 (02250.HK) has signed a contract to develop an AI marketing system to diversify revenue sources [2] Buyback and Financing Activities - 威海银行 (09677.HK) plans to issue up to approximately 758 million domestic shares and 154 million H-shares, raising nearly 3 billion yuan [2] Financial Results - 香港电讯-SS (06823.HK) reported total revenue of 17.322 billion HKD for the first half, a year-on-year increase of 4%, with a net profit of 2.07 billion HKD, also up 4% [4] - 青岛银行 (03866.HK) reported operating revenue of 7.662 billion yuan for the first half, a growth of 7.5%, and a net profit of 3.065 billion yuan, up 16.05% [4] - 中国石油化工股份 (00386.HK) expects mid-term net profit to be between 20.1 billion and 21.6 billion yuan, a year-on-year decline of 39.5%-43.7% [4] - 汽车之家-S (02518.HK) reported total revenue of 3.212 billion yuan for the first half, a decrease of 7.75%, with a net profit of 772 million yuan, down 15.99% [4] - 绿茶集团 (06831.HK) issued a profit warning, expecting mid-term net profit to be between 230 million and 237 million yuan, a year-on-year increase of approximately 32%-36% [4] - 粤海置地 (00124.HK) issued a profit warning, expecting mid-term net profit to exceed 260 million HKD, turning from loss to profit [4] - 药师帮 (09885.HK) issued a profit warning, expecting mid-term net profit to exceed 70 million yuan [4] - 中国东方教育 (00667.HK) issued a profit warning, expecting mid-term net profit to grow by 45%-50% year-on-year [4] - 中核国际 (02302.HK) issued a profit warning, expecting mid-term revenue to increase to at least 585 million HKD, with net profit of at least 9.5 million HKD [4] - 大唐环境 (01272.HK) issued a profit warning, expecting mid-term net profit to decrease to between 350 million and 400 million yuan [4] - 长江生命科技 (00775.HK) issued a profit warning, expecting mid-term net loss of approximately 150 million HKD, turning from profit to loss year-on-year [4] - 延长石油国际 (00346.HK) issued a profit warning, expecting mid-term loss of approximately 27.9 million HKD [4]

中国石化发布2025年半年度业绩预告显示，预计上半年实现归母净利润201亿元至216亿元，同比下降 39.5%至43.7%。业绩变动主要受国际原油价格下跌、市场竞争加剧及化工产品毛利下降等因素影响。 公司表示将持续优化生产经营，推动产业转型升级。 7月31日中国石化主力资金净流入1.17亿元，占流通市值的0.02%。 风险提示：投资有风险，入市需谨慎。 中国石化7月31日股价报6.01元，与前一交易日持平。当日开盘价为6.04元，最高触及6.06元，最低下探 5.90元，成交量为182.39万手，成交金额达10.87亿元。 中国石化属于石油行业板块，是中国最大的石油炼制商和石化产品生产商，业务涵盖油气勘探开发、石 油炼制、成品油销售、化工产品生产等全产业链。公司总部位于北京，同时在香港联交所上市。 来源:金融界 ...

今日聚焦 1、恒瑞医药：获得HRS-5041片临床试验批准通知书 恒瑞医药公告称，公司及子公司成都盛迪医药收到国家药监局核准签发的HRS-5041片《药物临床试验 批准通知书》，同意该药联合用药用于前列腺癌的临床试验。HRS-5041是公司开发的新型、高效、选 择性的AR-PROTAC(雄激素受体-蛋白降解靶向嵌合体)小分子，拟用于治疗前列腺癌。HRS-5041对野生 型及各类突变体的AR蛋白有显著的降解作用，与二代AR抑制剂相比，有克服耐药的潜力。经查询，目 前国内外暂时无同类产品获批上市。 2、万华化学：股东Prime Partner International Limited拟减持不超过0.54%公司股份 万华化学公告称，持股5%以上股东Prime Partner International Limited计划自减持计划公告之日起15个交 易日之后的3个月内，通过集中竞价及/或大宗交易方式减持不超过公司总股本0.54%的股份，即不超过 1700万股。减持原因为自身资金需求及财务计划。减持期间为2025年8月22日至2025年11月21日。减持 股份来源为非公开发行。 3、山鹰国际：拟29.77亿元设立合 ...

Core Viewpoint - The company anticipates a significant decline in net profit for the first half of 2025, primarily due to adverse market conditions and increased competition in the oil and petrochemical sectors [1] Group 1: Financial Performance - The company expects a net profit attributable to shareholders of 20.1 billion to 21.6 billion yuan for the first half of 2025, representing a year-on-year decrease of 39.5% to 43.7% [1] - The decline in profit is attributed to a sharp drop in international crude oil prices, intense competition in the oil and petrochemical markets, and low margins in the chemical market [1] Group 2: Operational Strategy - In response to the challenging operating environment, the company is intensifying efforts to optimize production and operations while strictly controlling costs and expenses [1]

Core Insights - The 2025 Fortune Global 500 list reveals that the total revenue of the listed companies for 2024 is approximately $41.7 trillion, representing a year-on-year growth of about 1.8%, exceeding one-third of the global GDP [1] - The total net profit of these companies has increased by approximately 0.4% year-on-year, amounting to around $2.98 trillion [1] - Walmart continues to lead as the largest company globally with revenues of approximately $681 billion, marking its twelfth consecutive year at the top [1] Company Rankings - JD.com ranks 44th, up 3 places from last year, maintaining its position as the highest-ranked private company from mainland China [2] - Alibaba's ranking improved by 7 places to 63rd, while Tencent rose 25 places to 116th [2] - Pinduoduo saw the most significant increase, climbing 176 places to 266th, and Meituan moved up 57 places to 327th [2] Profitability Insights - Saudi Aramco remains the most profitable company globally with a profit of approximately $105 billion, despite a year-on-year decline of about 13% [2] - Alphabet, the parent company of Google, ranks second in profitability with a net profit of $100.1 billion, surpassing Apple, which ranks third with $93.7 billion [2] - Berkshire Hathaway and Microsoft follow, with profits of over $88.9 billion and $88.1 billion, respectively [2] - Nvidia's profit surged by approximately 145% to around $72.9 billion, marking its first entry into the top ten profitability rankings [2] - The Industrial and Commercial Bank of China ranks as the highest Chinese company in net profit, exceeding $50.8 billion and placing 10th globally [2]

Group 1: Public Fund Industry - The total net asset value of public funds in China reached a historical high of 34.39 trillion yuan as of June 30, 2025, with a month-on-month increase of 651.9 billion yuan, representing a growth rate of 1.93% [1] Group 2: Technology and Security - The National Internet Information Office of China held discussions with NVIDIA regarding security risks associated with the H20 computing chip, following concerns about vulnerabilities and backdoor issues [2] - IDC predicts that the global robotics market will exceed $400 billion by 2029, with China accounting for nearly half of this market and leading with a compound annual growth rate of nearly 15% [2] Group 3: Gaming Industry - The domestic gaming market in China achieved a sales revenue of 168 billion yuan in the first half of 2025, marking a year-on-year growth of 14.08% and setting a new record [2] Group 4: Corporate Developments - Moutai's official authorized stores have begun to enter the Meituan flash purchase platform, indicating a strategic move to enhance distribution channels [3] - Huashan Fund experienced a significant personnel change, with Xu Yong appointed as the Party Secretary, potentially leading to a future role as Chairman [3] - Zhejiang Rural Commercial Bank's total asset scale surpassed 7 trillion yuan as of June 30, 2025, with a non-performing loan ratio of 0.94% [3] Group 5: Market Reactions - Three major steel companies announced a suspension of molybdenum iron procurement to combat irrational market speculation [3] Group 6: IPO and Financing - The China Securities Regulatory Commission approved the IPO registration of Yunhan Chip City on the Growth Enterprise Market [4] - Lege Co., Ltd. plans to register and issue medium-term notes not exceeding 800 million yuan to repay debts and supplement working capital [5][6] - Tianhe Magnetic Materials obtained a project filing notice for a 12,000-ton deep processing project with a total investment of 250 million yuan [7] Group 7: Financial Performance - Daodaquan reported a net profit of 181 million yuan for the first half of 2025, a year-on-year increase of 563.15% [9] - Jiejia Weichuang expects a net profit increase of 38.65% to 59.85% for the first half of 2025, projecting a profit between 1.7 billion and 1.96 billion yuan [10] - Sinopec anticipates a net profit decline of 39.5% to 43.7% for the first half of 2025, estimating profits between 20.1 billion and 21.6 billion yuan [11] Group 8: Market Overview - The A-share market experienced fluctuations, with the ChiNext index rising over 8% in July, while the Shanghai Composite Index lost the 3600-point mark [12]